Issue: January 2014
January 01, 2014
1 min read
Save
This article is more than 5 years old. Information may no longer be current.
Top 10 Stories of 2013
Issue: January 2014
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
The following are the top 10 stories of 2013 in the field of cardiology. These developments and issues were selected and deemed important by members of the Cardiology Today Editorial Board.
- New 2013 CV risk and treatment guidelines from ACC, AHA and The Obesity Society
- Growing excitement surrounding the benefits of renal denervation for resistant hypertension and other conditions
- Continued enthusiasm about PCSK9 inhibition
- HPS2-THRIVE study: Niacin therapy not beneficial for vascular disease
- AMA declares obesity a disease state
- How to best position the novel oral anticoagulants for the right patients
- Mounting data on the Watchman device as a promising treatment for stroke prevention in atrial fibrillation
- MitraClip approval by the FDA
- Much-anticipated results from the TOPCAT trial of aldosterone antagonist in HFpEF
- CORAL study: Renal stenting failed to reduce clinical events vs. medical therapy